Trait centric view

1. Trait name:	Milk fat yield
   Ontology terms:	VT:1000161, LPT:0010027, CMO:0000814

   468 genes are associated with this trait, with QTL/association found

   • A2ML1: Alpha-2-macroglobulin like 1
     evidenced by: QTL:174088;
   • AAAS: Aladin WD repeat nucleoporin
     evidenced by: QTL:175848;
   • AASDHPPT: Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
     evidenced by: QTL:175913;
   • ABCA1: ATP binding cassette subfamily A member 1
     evidenced by: QTL:181829;
   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:174019; QTL:174020; QTL:174021; QTL:174022;
   • ABCG2: ATP-binding cassette, sub-family G (WHITE), member 2
     evidenced by: QTL:10487;
   • ABTB2: Ankyrin repeat and BTB domain containing 2
     evidenced by: QTL:174293;
   • ACACB: Acetyl-CoA carboxylase beta
     evidenced by: QTL:153261; QTL:153265; QTL:153273; QTL:153278; QTL:153280; QTL:153285; QTL:153288; QTL:153291; QTL:153295; QTL:153299; QTL:153303; QTL:153308; QTL:153311; QTL:153314; QTL:153318; QTL:153321; QTL:153325; QTL:153328; QTL:153332; QTL:153336; QTL:153339; QTL:153344; QTL:153347; QTL:153350; QTL:153356; QTL:153359; QTL:153362; QTL:153374; QTL:153379; QTL:153385; QTL:153391; QTL:153395; QTL:153401; QTL:153405; QTL:153408; QTL:153411; QTL:153415; QTL:153419; QTL:153423;
   • ACADVL: Acyl-CoA dehydrogenase very long chain
     evidenced by: QTL:282758; QTL:282760; QTL:282764; QTL:282770; QTL:282775; QTL:282779; QTL:282782; QTL:282785; QTL:282786; QTL:282790; QTL:282793; QTL:282797; QTL:282799; QTL:282802; QTL:282803;
   • ACAT2: Acetyl-CoA acetyltransferase 2
     evidenced by: QTL:181823;
   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45064;
   • ACSBG2: Acyl-CoA synthetase bubblegum family member 2
     evidenced by: QTL:172748;
   • ACTE1: Actin epsilon 1
     evidenced by: QTL:54001;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53540;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45547; QTL:45561;
   • ADGRB1: Adhesion G protein-coupled receptor B1
     evidenced by: QTL:174185; QTL:174186; QTL:174187;
   • AFF2: AF4/FMR2 family member 2
     evidenced by: QTL:54499;
   • AGO2: Argonaute 2, RISC catalytic component
     evidenced by: QTL:174212; QTL:174213;
   • AGPAT6: 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta)
     evidenced by: QTL:136287;
   • ALDH18A1: Aldehyde dehydrogenase 18 family member A1
     evidenced by: QTL:261673; QTL:261677; QTL:261680; QTL:261685; QTL:261688; QTL:261690; QTL:261694; QTL:261697; QTL:261699; QTL:261711; QTL:261714; QTL:261717;
   • ALDH5A1: Aldehyde dehydrogenase 5 family member A1
     evidenced by: QTL:52232;
   • AMN1: Antagonist of mitotic exit network 1 homolog
     evidenced by: QTL:173987; QTL:173988;
   • ANK1: Ankyrin 1, erythrocytic
     evidenced by: QTL:175923;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50012;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42314;
   • ANKRD44: Ankyrin repeat domain 44
     evidenced by: QTL:156648; QTL:168157;
   • ANO2: Anoctamin 2
     evidenced by: QTL:174092; QTL:223342;
   • ANO3: Anoctamin 3
     evidenced by: QTL:174267; QTL:174268; QTL:174269;
   • ANXA9: Annexin A9
     evidenced by: QTL:12705;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:42047;
   • APLF: Aprataxin and PNKP like factor
     evidenced by: QTL:45507;
   • APP: Amyloid beta precursor protein
     evidenced by: QTL:38155;
   • ARAP1: ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
     evidenced by: QTL:174253;
   • ARHGAP22: Rho GTPase activating protein 22
     evidenced by: QTL:53851;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43063; QTL:43080;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55458;
   • ARHGEF12: Rho guanine nucleotide exchange factor 12
     evidenced by: QTL:47853;
   • ARHGEF28: Rho guanine nucleotide exchange factor 28
     evidenced by: QTL:214766; QTL:214850;
   • ARHGEF9: Cdc42 guanine nucleotide exchange factor 9
     evidenced by: QTL:54837;
   • ARMC1: Armadillo repeat containing 1
     evidenced by: QTL:18878;
   • ARNTL: Aryl hydrocarbon receptor nuclear translocator like
     evidenced by: QTL:256249; QTL:256254; QTL:256258; QTL:256284; QTL:256288;
   • ARPIN: Actin related protein 2/3 complex inhibitor
     evidenced by: QTL:51116;
   • ARRB1: Arrestin beta 1
     evidenced by: QTL:174262;
   • ARSG: Arylsulfatase G
     evidenced by: QTL:50250;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53318;
   • ASCL1: Achaete-scute family bHLH transcription factor 1
     evidenced by: QTL:173974;
   • ATF3: Activating transcription factor 3
     evidenced by: QTL:135465; QTL:135468; QTL:135471; QTL:135475; QTL:135479; QTL:135482; QTL:135485; QTL:135488; QTL:135492; QTL:135494; QTL:135496; QTL:135499; QTL:135502; QTL:135506; QTL:135508; QTL:135512; QTL:135515; QTL:135518; QTL:135521; QTL:135523; QTL:135526; QTL:135529; QTL:135532; QTL:135536; QTL:135540; QTL:135544; QTL:135548; QTL:135551; QTL:135554; QTL:135557; QTL:135581; QTL:135586;
   • ATF7: Activating transcription factor 7
     evidenced by: QTL:175849;
   • ATP5MC2: ATP synthase membrane subunit c locus 2
     evidenced by: QTL:175850;
   • AURKA: Aurora kinase A
     evidenced by: QTL:47315;
   • B4GALNT3: Beta-1,4-N-acetyl-galactosaminyltransferase 3
     evidenced by: QTL:175851;
   • BAG2: BAG cochaperone 2
     evidenced by: QTL:51926;
   • BBOX1: Gamma-butyrobetaine hydroxylase 1
     evidenced by: QTL:174271;
   • BCL2L14: BCL2 like 14
     evidenced by: QTL:174078;
   • BEST3: Bestrophin 3
     evidenced by: QTL:40912;
   • BIN2: Bridging integrator 2
     evidenced by: QTL:175852;
   • BTRC: Beta-transducin repeat containing
     evidenced by: QTL:174330; QTL:174331;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49666;
   • C2CD3: C2 domain containing 3 centriole elongation regulator
     evidenced by: QTL:174256; QTL:174257;
   • C2CD5: C2 calcium dependent domain containing 5
     evidenced by: QTL:174013; QTL:174014;
   • CACNA1C: Calcium voltage-gated channel subunit alpha1 C
     evidenced by: QTL:174099;
   • CACNG5: Calcium voltage-gated channel auxiliary subunit gamma 5
     evidenced by: QTL:50270;
   • CACUL1: CDK2 associated cullin domain 1
     evidenced by: QTL:174348;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40625;
   • CAPRIN1: Cell cycle associated protein 1
     evidenced by: QTL:174291;
   • CASC1: Cancer susceptibility 1
     evidenced by: QTL:174006;
   • CAST: Calpastatin
     evidenced by: QTL:57251;
   • CBX6: Chromobox 6
     evidenced by: QTL:175853;
   • CCDC57: Coiled-coil domain containing 57
     evidenced by: QTL:174304; QTL:214765; QTL:214849;
   • CCDC69: Coiled-coil domain containing 69
     evidenced by: QTL:43217;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41331;
   • CD14: CD14 molecule
     evidenced by: QTL:14038; QTL:57252;
   • CDCA2: Cell division cycle associated 2
     evidenced by: QTL:174134;
   • CDKN1A: Cyclin dependent kinase inhibitor 1A
     evidenced by: QTL:135562; QTL:135567; QTL:135573; QTL:135577; QTL:135591;
   • CENPC: Centromere protein C
     evidenced by: QTL:174104;
   • CENPE: Centromere protein E
     evidenced by: QTL:172733; QTL:172739; QTL:172742; QTL:172760;
   • CERS5: Ceramide synthase 5
     evidenced by: QTL:40845;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39108;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53734;
   • CHST11: Carbohydrate sulfotransferase 11
     evidenced by: QTL:173976;
   • CHUK: Component of inhibitor of nuclear factor kappa B kinase complex
     evidenced by: QTL:174322;
   • CKAP4: Cytoskeleton associated protein 4
     evidenced by: QTL:173977;
   • CLEC4A: C-type lectin domain family 4 member A
     evidenced by: QTL:174089;
   • CLU: Clusterin
     evidenced by: QTL:18796;
   • CNNM2: Cyclin and CBS domain divalent metal cation transport mediator 2
     evidenced by: QTL:174336; QTL:175922;
   • CNOT1: CCR4-NOT transcription complex, subunit 1
     evidenced by: QTL:16253;
   • CNST: Consortin, connexin sorting protein
     evidenced by: QTL:168262;
   • CNTN5: Contactin 5
     evidenced by: QTL:47784;
   • COL1A2: Collagen type I alpha 2 chain
     evidenced by: QTL:125154;
   • COL22A1: Collagen type XXII alpha 1 chain
     evidenced by: QTL:174230;
   • COL4A4: Collagen type IV alpha 4 chain
     evidenced by: QTL:39574;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54594;
   • COX15: COX15, cytochrome c oxidase assembly homolog
     evidenced by: QTL:156667; QTL:168268;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:40661;
   • CPSF1: Cleavage and polyadenylation specific factor 1, 160kDa
     evidenced by: QTL:214839; QTL:57253;
   • CPSF3: Cleavage and polyadenylation specific factor 3
     evidenced by: QTL:46018;
   • CRACR2A: Calcium release activated channel regulator 2A
     evidenced by: QTL:174098; QTL:175854;
   • CRTAC1: Cartilage acidic protein 1
     evidenced by: QTL:174312; QTL:174313; QTL:174314;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:175855; QTL:40830;
   • CSGALNACT1: Chondroitin sulfate N-acetylgalactosaminyltransferase 1
     evidenced by: QTL:53591;
   • CSN1S1: Casein alpha s1
     evidenced by: QTL:136197;
   • CSN2: Casein beta
     evidenced by: QTL:10470;
   • CSN3: Casein kappa
     evidenced by: QTL:10467; QTL:13569; QTL:136219;
   • CSTF3: Cleavage stimulation factor subunit 3
     evidenced by: QTL:174290;
   • CTNNA2: Catenin alpha 2
     evidenced by: QTL:156658;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53762;
   • CUL2: Cullin 2
     evidenced by: QTL:46814;
   • CUL3: Cullin 3
     evidenced by: QTL:39543;
   • CXCR1: Chemokine (C-X-C motif) receptor 1
     evidenced by: QTL:14035; QTL:31621;
   • CXCR2: C-X-C motif chemokine receptor 2
     evidenced by: QTL:263448;
   • CYHR1: Cysteine and histidine rich 1
     evidenced by: QTL:174147;
   • CYP21: Cytochrome P450, subfamily XXI (steroid 21-hydroxylase)
     evidenced by: QTL:2567;
   • CYP7A1: Cytochrome P450, family 7, subfamily A, polypeptide 1
     evidenced by: QTL:296673; QTL:296676; QTL:296679; QTL:296682; QTL:296685; QTL:296687; QTL:296704; QTL:296707; QTL:296710; QTL:296713;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46326;
   • DCDC1: Doublecortin domain containing 1
     evidenced by: QTL:174287;
   • DCHS1: Dachsous cadherin-related 1
     evidenced by: QTL:174246;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38493;
   • DDIT3: DNA damage inducible transcript 3
     evidenced by: QTL:168859; QTL:168863; QTL:168867; QTL:169686;
   • DENND3: DENN domain containing 3
     evidenced by: QTL:174203;
   • DERA: Deoxyribose-phosphate aldolase
     evidenced by: QTL:174055;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:101366; QTL:101368; QTL:101370; QTL:101372; QTL:101374; QTL:10261; QTL:10400; QTL:10405; QTL:10574; QTL:10575; QTL:10610; QTL:10611; QTL:121760; QTL:121765; QTL:12214; QTL:126967; QTL:126968; QTL:126969; QTL:130541; QTL:156660; QTL:168256; QTL:168257; QTL:174149; QTL:175909; QTL:181821; QTL:181822; QTL:214755; QTL:223330; QTL:223332; QTL:223336; QTL:223337; QTL:223338; QTL:223339; QTL:24984; QTL:31659; QTL:31664; QTL:3508; QTL:3513; QTL:36314; QTL:4582; QTL:9978;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53094;
   • DIS3L2: DIS3 like 3'-5' exoribonuclease 2
     evidenced by: QTL:173960;
   • DNAJC24: DnaJ heat shock protein family (Hsp40) member C24
     evidenced by: QTL:174288;
   • DNMBP: Dynamin binding protein
     evidenced by: QTL:174320;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53113;
   • DOCK5: Dedicator of cytokinesis 5
     evidenced by: QTL:43685;
   • DTNB: Dystrobrevin beta
     evidenced by: QTL:45536;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43248;
   • EEF1D: Eukaryotic translation elongation factor 1 delta
     evidenced by: QTL:174167;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41925;
   • EIF2B3: Eukaryotic translation initiation factor 2B subunit gamma
     evidenced by: QTL:40187;
   • EMP1: Epithelial membrane protein 1
     evidenced by: QTL:174073;
   • ENTHD1: ENTH domain containing 1
     evidenced by: QTL:41607;
   • EP400: E1A binding protein p400
     evidenced by: QTL:215050;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44098;
   • EPPK1: Epiplakin 1
     evidenced by: QTL:174160;
   • EPS8: Epidermal growth factor receptor pathway substrate 8
     evidenced by: QTL:174056; QTL:174057; QTL:174058;
   • ERBB2: Erb-b2 receptor tyrosine kinase 2
     evidenced by: QTL:167460; QTL:167465; QTL:167475;
   • ERC1: ELKS/RAB6-interacting/CAST family member 1
     evidenced by: QTL:175856; QTL:175857; QTL:175858;
   • EXOC4: Exocyst complex component 4
     evidenced by: QTL:40674;
   • EXT1: Exostosin glycosyltransferase 1
     evidenced by: QTL:47619;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49440;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:256850; QTL:256859; QTL:256860; QTL:256864; QTL:256868; QTL:256869; QTL:256873; QTL:256874; QTL:256879; QTL:256880; QTL:256883; QTL:256884; QTL:256890; QTL:256891; QTL:256899; QTL:256900; QTL:256906; QTL:256907; QTL:256913; QTL:256914; QTL:256921; QTL:256924; QTL:256927; QTL:256932;
   • FAM134B: Family with sequence similarity 134 member B
     evidenced by: QTL:50911;
   • FAM135B: Family with sequence similarity 135 member B
     evidenced by: QTL:174232; QTL:174233; QTL:174234;
   • FAM168A: Family with sequence similarity 168 member A
     evidenced by: QTL:174255;
   • FASN: Fatty acid synthase
     evidenced by: QTL:174305; QTL:28089; QTL:28094; QTL:31677;
   • FBF1: Fas binding factor 1
     evidenced by: QTL:50131;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51392;
   • FER1L5: Fer-1 like family member 5
     evidenced by: QTL:45087;
   • FGD4: FYVE, RhoGEF and PH domain containing 4
     evidenced by: QTL:173986;
   • FGF2: Fibroblast growth factor 2 (basic)
     evidenced by: QTL:136250;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51735;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51345;
   • FTO: Fat mass and obesity associated
     evidenced by: QTL:30814; QTL:30815;
   • FUT10: Fucosyltransferase 10
     evidenced by: QTL:53466;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:16171; QTL:174082; QTL:41522;
   • GALE: UDP-galactose-4-epimerase
     evidenced by: QTL:263417; QTL:263421; QTL:263425; QTL:263429;
   • GASK1B: Golgi associated kinase 1B
     evidenced by: QTL:181827;
   • GBF1: Golgi brefeldin A resistant guanine nucleotide exchange factor 1
     evidenced by: QTL:174332;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:174112; QTL:174113;
   • GH1: Growth hormone 1
     evidenced by: QTL:14076; QTL:14077; QTL:14078; QTL:14079; QTL:14080;
   • GHR: Growth hormone receptor
     evidenced by: QTL:121743; QTL:121747; QTL:12869; QTL:12870; QTL:12871; QTL:12872; QTL:12873; QTL:12874; QTL:12875; QTL:12876;
   • GHRL: Ghrelin/obestatin prepropeptide
     evidenced by: QTL:125150;
   • GLT8D2: Glycosyltransferase 8 domain containing 2
     evidenced by: QTL:173975;
   • GLYCAM1: Glycosylation-dependent cell adhesion molecule 1
     evidenced by: QTL:175859;
   • GML: Glycosylphosphatidylinositol anchored molecule like
     evidenced by: QTL:174177; QTL:174178;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55440;
   • GPR20: G protein-coupled receptor 20
     evidenced by: QTL:174199;
   • GRIA4: Glutamate ionotropic receptor AMPA type subunit 4
     evidenced by: QTL:175914;
   • GRIK2: Glutamate ionotropic receptor kainate type subunit 2
     evidenced by: QTL:43999;
   • GRIN2B: Glutamate ionotropic receptor NMDA type subunit 2B
     evidenced by: QTL:174066; QTL:174067; QTL:174068; QTL:175860;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49684;
   • GUCY2C: Guanylate cyclase 2C
     evidenced by: QTL:125157;
   • HADHB: Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
     evidenced by: QTL:296691; QTL:296696; QTL:296701; QTL:296715; QTL:296718;
   • HERC6: Hect domain and RLD 6
     evidenced by: QTL:10491;
   • HHAT: Hedgehog acyltransferase
     evidenced by: QTL:48483;
   • HOXC8: Homeobox C8
     evidenced by: QTL:175861;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45967; QTL:45978;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:174315; QTL:52752; QTL:52763; QTL:52776;
   • HSF1: Heat shock transcription factor 1
     evidenced by: QTL:214748; QTL:214832; QTL:223331; QTL:223334; QTL:223335; QTL:223341;
   • HSPA8: Heat shock protein family A (Hsp70) member 8
     evidenced by: QTL:167452; QTL:167455;
   • IDH1: Isocitrate dehydrogenase 1 (NADP+), soluble
     evidenced by: QTL:16152;
   • IDH2: Isocitrate dehydrogenase (NADP(+)) 2
     evidenced by: QTL:315651; QTL:315652; QTL:315657; QTL:315662; QTL:315663; QTL:315670; QTL:315671; QTL:315677; QTL:315697; QTL:315698;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:13039; QTL:19052; QTL:19053; QTL:20618; QTL:20625;
   • IGF1R: Insulin-like growth factor 1 receptor
     evidenced by: QTL:122159; QTL:122160; QTL:122161; QTL:122162; QTL:122163; QTL:122164; QTL:122165; QTL:122166; QTL:122167; QTL:122190; QTL:122191; QTL:122192; QTL:122193; QTL:122194; QTL:122195; QTL:122196; QTL:122197; QTL:122198; QTL:122223; QTL:122224; QTL:122225; QTL:122226; QTL:122227; QTL:122228; QTL:122229;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:13047;
   • IGFBP7: Insulin-like growth factor binding protein 7
     evidenced by: QTL:16234;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54536;
   • IL2RB: Interleukin 2 receptor subunit beta
     evidenced by: QTL:167337;
   • IL8: Interleukin 8
     evidenced by: QTL:15948; QTL:263439; QTL:9939;
   • IL8R: Interleukin 8 receptor
     evidenced by: QTL:9943;
   • IQANK1: IQ motif and ankyrin repeat containing 1
     evidenced by: QTL:174164;
   • IQSEC3: IQ motif and Sec7 domain 3
     evidenced by: QTL:175862;
   • IRF6: Interferon regulatory factor 6
     evidenced by: QTL:282808; QTL:282812; QTL:282815; QTL:282817; QTL:282822; QTL:282829; QTL:282832; QTL:282837; QTL:282840; QTL:282845; QTL:282848; QTL:282853; QTL:282857; QTL:282862;
   • IRF9: Interferon regulatory factor 9
     evidenced by: QTL:16243;
   • ITGA1: Integrin subunit alpha 1
     evidenced by: QTL:175917;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:46031;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51424;
   • ITPR2: Inositol 1,4,5-trisphosphate receptor, type 2
     evidenced by: QTL:173996; QTL:173997; QTL:173998;
   • KAZN: Kazrin, periplakin interacting protein
     evidenced by: QTL:174301;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41968;
   • KCNK9: Potassium two pore domain channel subfamily K member 9
     evidenced by: QTL:174222; QTL:174223;
   • KCNQ3: Potassium voltage-gated channel subfamily Q member 3
     evidenced by: QTL:125162;
   • KCNT1: Potassium sodium-activated channel subfamily T member 1
     evidenced by: QTL:46121;
   • KCTD16: Potassium channel tetramerization domain containing 16
     evidenced by: QTL:156654; QTL:168163;
   • KDM3B: Lysine demethylase 3B
     evidenced by: QTL:174130;
   • KDM4C: Lysine demethylase 4C
     evidenced by: QTL:43617; QTL:43626; QTL:43635;
   • KHDRBS2: KH RNA binding domain containing, signal transduction associated 2
     evidenced by: QTL:51872;
   • KLF6: KLF transcription factor 6
     evidenced by: QTL:314329; QTL:314334; QTL:314338; QTL:314343; QTL:314346; QTL:314351; QTL:314359; QTL:314364; QTL:314369; QTL:314373; QTL:314377; QTL:314382; QTL:314386; QTL:314391; QTL:314394; QTL:314399; QTL:314404; QTL:314412; QTL:314415; QTL:314420;
   • KLHL1: Kelch like family member 1
     evidenced by: QTL:46313;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47841;
   • KRT75: Keratin 75
     evidenced by: QTL:175863;
   • KSR2: Kinase suppressor of ras 2
     evidenced by: QTL:16248;
   • LAMA4: Laminin subunit alpha 4
     evidenced by: QTL:156655; QTL:168164;
   • LAP3: Leucine aminopeptidase 3
     evidenced by: QTL:10476; QTL:261794;
   • LDHA: Lactate dehydrogenase A
     evidenced by: QTL:315681; QTL:315682;
   • LDHB: Lactate dehydrogenase B
     evidenced by: QTL:315685; QTL:315688; QTL:315692; QTL:315693;
   • LDLRAD3: Low density lipoprotein receptor class A domain containing 3
     evidenced by: QTL:174300;
   • LEP: Leptin
     evidenced by: QTL:31174; QTL:31624; QTL:31628;
   • LGI1: Leucine rich glioma inactivated 1
     evidenced by: QTL:174310;
   • LIN7A: Lin-7 homolog A, crumbs cell polarity complex component
     evidenced by: QTL:40739; QTL:40756;
   • LIPA: Lipase A, lysosomal acid, cholesterol esterase
     evidenced by: QTL:16200;
   • LIPT2: Lipoyl(octanoyl) transferase 2
     evidenced by: QTL:47913;
   • LMNTD1: Lamin tail domain containing 1
     evidenced by: QTL:174000; QTL:174001; QTL:174002;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:174105;
   • LOC100140503: Alpha-fetoprotein-like
     evidenced by: QTL:174118;
   • LOC100848575: Killer cell lectin-like receptor subfamily E member 1
     evidenced by: QTL:174081;
   • LOC100848939: Uncharacterized LOC100848939
     evidenced by: QTL:174181; QTL:174182;
   • LOC101901918: Uncharacterized LOC101901918
     evidenced by: QTL:174196;
   • LOC101906736: Uncharacterized LOC101906736
     evidenced by: QTL:174119;
   • LOC101908561: Uncharacterized LOC101908561
     evidenced by: QTL:174090;
   • LOC104968898: Uncharacterized LOC104968898
     evidenced by: QTL:174120;
   • LOC104972567: Uncharacterized LOC104972567
     evidenced by: QTL:174095;
   • LOC104974257: Uncharacterized LOC104974257
     evidenced by: QTL:174244;
   • LOC104974297: Uncharacterized LOC104974297
     evidenced by: QTL:174294;
   • LOC107131181: Leucine-rich glioma-inactivated protein 1-like
     evidenced by: QTL:174309;
   • LOC107131873: 60S ribosomal protein L21 pseudogene
     evidenced by: QTL:174316;
   • LOC511498: Cytochrome P450, family 2, subfamily c
     evidenced by: QTL:174321;
   • LOC617565: C-type lectin domain family 2 member D11
     evidenced by: QTL:175865;
   • LOC785540: Cytochrome P450 2C31
     evidenced by: QTL:174311;
   • LOC787628: Cytochrome P450 11B1, mitochondrial
     evidenced by: QTL:174176;
   • LOC788286: Apolipoprotein L3-like
     evidenced by: QTL:173982;
   • LOC788871: Zinc finger protein 85-like
     evidenced by: QTL:24987;
   • LOXL2: Lysyl oxidase like 2
     evidenced by: QTL:174132;
   • LPIN1: Lipin 1
     evidenced by: QTL:170540; QTL:170548; QTL:170556; QTL:170559; QTL:170563; QTL:170566; QTL:170568; QTL:170570;
   • LPL: Lipoprotein lipase
     evidenced by: QTL:136234;
   • LTF: Lactotransferrin
     evidenced by: QTL:136278; QTL:1536;
   • LY6E: Lymphocyte antigen 6 family member E
     evidenced by: QTL:174174;
   • MACROD2: MACRO domain containing 2
     evidenced by: QTL:43696;
   • MAF1: MAF1 homolog, negative regulator of RNA polymerase III
     evidenced by: QTL:174153;
   • MAML3: Mastermind like transcriptional coactivator 3
     evidenced by: QTL:48974;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54917;
   • MAP6: Microtubule associated protein 6
     evidenced by: QTL:174263;
   • MAPK15: Mitogen-activated protein kinase 15
     evidenced by: QTL:174165;
   • MASP2: MBL associated serine protease 2
     evidenced by: QTL:314108;
   • MAT2A: Methionine adenosyltransferase 2A
     evidenced by: QTL:261707;
   • MBNL3: Muscleblind like splicing regulator 3
     evidenced by: QTL:54318;
   • MCM8: Minichromosome maintenance 8 homologous recombination repair factor
     evidenced by: QTL:47128;
   • MDM1: Mdm1 nuclear protein
     evidenced by: QTL:40916;
   • MED28: Mediator complex subunit 28
     evidenced by: QTL:10473;
   • METTL15: Methyltransferase like 15
     evidenced by: QTL:174274;
   • MGP: Matrix Gla protein
     evidenced by: QTL:16176;
   • MGST1: Microsomal glutathione S-transferase 1
     evidenced by: QTL:156650; QTL:168159; QTL:214817;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:52007;
   • MPPED2: Metallophosphoesterase domain containing 2
     evidenced by: QTL:174283;
   • MROH1: Maestro heat-like repeat family member 1
     evidenced by: QTL:174150; QTL:174151; QTL:174152;
   • MSN: Moesin
     evidenced by: QTL:54828;
   • MSTN: Myostatin
     evidenced by: QTL:18826;
   • MTMR3: Myotubularin related protein 3
     evidenced by: QTL:16185;
   • MTSS1: Metastasis suppressor 1
     evidenced by: QTL:174241;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40986;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46535;
   • NAT10: N-acetyltransferase 10
     evidenced by: QTL:174292;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:45725; QTL:45743;
   • NCKAP1L: NCK associated protein 1 like
     evidenced by: QTL:175866;
   • NCOA1: Nuclear receptor coactivator 1
     evidenced by: QTL:45574;
   • NCSTN: Nicastrin
     evidenced by: QTL:39716;
   • NDP: Norrin cystine knot growth factor NDP
     evidenced by: QTL:54904;
   • NDRG4: NDRG family member 4
     evidenced by: QTL:16255;
   • NELL2: Neural EGFL like 2
     evidenced by: QTL:173971; QTL:175867;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41676;
   • NFX1: Nuclear transcription factor, X-box binding 1
     evidenced by: QTL:174135;
   • NGFR: Nerve growth factor receptor
     evidenced by: QTL:256234; QTL:256236; QTL:256238; QTL:256241; QTL:256243; QTL:256245; QTL:256278; QTL:256280;
   • NHSL1: NHS like 1
     evidenced by: QTL:44140;
   • NINJ2: Ninjurin 2
     evidenced by: QTL:175868;
   • NOD2: Nucleotide-binding oligomerization domain containing 2
     evidenced by: QTL:9988;
   • NOS1AP: Nitric oxide synthase 1 adaptor protein
     evidenced by: QTL:156649; QTL:168158;
   • NPC1: Niemann-Pick disease, type C1
     evidenced by: QTL:16272;
   • NR1H3: Nuclear receptor subfamily 1 group H member 3
     evidenced by: QTL:136247;
   • NR4A1: Nuclear receptor subfamily 4 group A member 1
     evidenced by: QTL:169025; QTL:169028; QTL:169031; QTL:169039; QTL:169044; QTL:169046; QTL:169051; QTL:169054; QTL:169064; QTL:169067; QTL:169711;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53806; QTL:53822;
   • NRSN2: Neurensin 2
     evidenced by: QTL:47328;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42578;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41053;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44082;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:176537; QTL:176538; QTL:176548; QTL:176553; QTL:176554; QTL:176559; QTL:176563; QTL:176568; QTL:176574; QTL:176580;
   • OPLAH: 5-oxoprolinase
     evidenced by: QTL:125161;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:173973;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46627;
   • PALLD: Palladin, cytoskeletal associated protein
     evidenced by: QTL:223343;
   • PARD3: Par-3 family cell polarity regulator
     evidenced by: QTL:46859; QTL:46875;
   • PARM1: Prostate androgen-regulated mucin-like protein 1
     evidenced by: QTL:57254;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53780;
   • PCDHA13: Protocadherin alpha 13
     evidenced by: QTL:43047;
   • PCED1B: PC-esterase domain containing 1B
     evidenced by: QTL:175869;
   • PCIF1: Phosphorylated CTD interacting factor 1
     evidenced by: QTL:47371;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:175870; QTL:40811;
   • PDE4B: Phosphodiesterase 4B
     evidenced by: QTL:223345; QTL:223346;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50694; QTL:50714;
   • PDE9A: Phosphodiesterase 9A
     evidenced by: QTL:64791; QTL:64795; QTL:64798; QTL:64801; QTL:64804;
   • PDGFRB: Platelet derived growth factor receptor beta
     evidenced by: QTL:43178;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39731;
   • PHEX: Phosphate regulating endopeptidase homolog X-linked
     evidenced by: QTL:55155; QTL:55169;
   • PHF20: PHD finger protein 20
     evidenced by: QTL:47338;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43719;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55218;
   • PIGN: Phosphatidylinositol glycan anchor biosynthesis class N
     evidenced by: QTL:52447;
   • PIK3C2G: Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma
     evidenced by: QTL:174039; QTL:174040; QTL:174041; QTL:174042; QTL:174043;
   • PITRM1: Pitrilysin metallopeptidase 1
     evidenced by: QTL:47109;
   • PKD2L1: Polycystin 2 like 1, transient receptor potential cation channel
     evidenced by: QTL:174323;
   • PKHD1: PKHD1, fibrocystin/polyductin
     evidenced by: QTL:223344;
   • PKLR: Pyruvate kinase L/R
     evidenced by: QTL:261445; QTL:261447; QTL:261449; QTL:261451; QTL:261455; QTL:261458; QTL:261462; QTL:261464; QTL:261467; QTL:261469; QTL:261472; QTL:261476; QTL:261479; QTL:261482; QTL:261484; QTL:261487; QTL:261489; QTL:261492; QTL:261495; QTL:261497; QTL:261500; QTL:261502; QTL:261505; QTL:261507; QTL:261510; QTL:261512; QTL:261515; QTL:261517; QTL:261519; QTL:261521; QTL:261524; QTL:261526; QTL:261528; QTL:261531; QTL:261534; QTL:261536; QTL:261539; QTL:261541; QTL:261543; QTL:261546; QTL:261547;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:46611;
   • PLEC: Plectin
     evidenced by: QTL:174158;
   • PLEKHA5: Pleckstrin homology domain containing A5
     evidenced by: QTL:174031; QTL:174032; QTL:174033; QTL:174034; QTL:261839;
   • PLXNC1: Plexin C1
     evidenced by: QTL:175871;
   • PMP22: Peripheral myelin protein 22
     evidenced by: QTL:49969;
   • POLD3: DNA polymerase delta 3, accessory subunit
     evidenced by: QTL:174259; QTL:174260;
   • POLR3B: RNA polymerase III subunit B
     evidenced by: QTL:173978;
   • PPARGC1A: Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
     evidenced by: QTL:12031;
   • PPFIBP1: PPFIA binding protein 1
     evidenced by: QTL:173995;
   • PPM1H: Protein phosphatase, Mg2+/Mn2+ dependent 1H
     evidenced by: QTL:175872;
   • PPME1: Protein phosphatase methylesterase 1
     evidenced by: QTL:174258;
   • PPP1R16A: Protein phosphatase 1 regulatory subunit 16A
     evidenced by: QTL:174146; QTL:175910;
   • PPP2R2B: Protein phosphatase 2 regulatory subunit Bbeta
     evidenced by: QTL:256262; QTL:256265; QTL:256267; QTL:256268; QTL:256271;
   • PRICKLE1: Prickle planar cell polarity protein 1
     evidenced by: QTL:40883;
   • PRLR: Prolactin receptor
     evidenced by: QTL:121756; QTL:31679; QTL:5638; QTL:5639;
   • PRMT8: Protein arginine methyltransferase 8
     evidenced by: QTL:175873;
   • PRNP: Prion protein
     evidenced by: QTL:2555; QTL:3611; QTL:3612; QTL:3613; QTL:3625; QTL:3626; QTL:1515; QTL:1675; QTL:2737; QTL:3635; QTL:2692; QTL:1726; QTL:3368;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46106;
   • PTBP2: Polypyrimidine tract binding protein 2
     evidenced by: QTL:39784;
   • PTK2: Protein tyrosine kinase 2
     evidenced by: QTL:174207; QTL:174208; QTL:47461; QTL:71143;
   • PTPN11: Protein tyrosine phosphatase non-receptor type 11
     evidenced by: QTL:181826;
   • PTPRO: Protein tyrosine phosphatase, receptor type O
     evidenced by: QTL:174059; QTL:174060;
   • PTPRR: Protein tyrosine phosphatase, receptor type R
     evidenced by: QTL:173972;
   • PUS7L: Pseudouridine synthase 7 like
     evidenced by: QTL:175874;
   • RASAL1: RAS protein activator like 1
     evidenced by: QTL:181828;
   • RASSF8: Ras association domain family member 8
     evidenced by: QTL:173999;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:42034;
   • RBMS3: RNA binding motif single stranded interacting protein 3
     evidenced by: QTL:51528;
   • RCAN2: Regulator of calcineurin 2
     evidenced by: QTL:52130;
   • RERG: RAS like estrogen regulated growth inhibitor
     evidenced by: QTL:174061; QTL:174062;
   • RETSAT: Retinol saturase
     evidenced by: QTL:172745;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41100;
   • RHPN1: Rhophilin Rho GTPase binding protein 1
     evidenced by: QTL:174170;
   • RIC8B: RIC8 guanine nucleotide exchange factor B
     evidenced by: QTL:173979;
   • RNF10: Ring finger protein 10
     evidenced by: QTL:49400;
   • RNF157: Ring finger protein 157
     evidenced by: QTL:50088;
   • ROBO1: Roundabout, axon guidance receptor, homolog 1 (Drosophila)
     evidenced by: QTL:2499;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45920;
   • RPL23A: Ribosomal protein L23a
     evidenced by: QTL:168872; QTL:168879; QTL:168882; QTL:168885; QTL:168887; QTL:168891; QTL:168895; QTL:168898; QTL:168902; QTL:168905; QTL:168909; QTL:168914; QTL:168918; QTL:168922; QTL:168926; QTL:168929; QTL:168932; QTL:168937; QTL:168941; QTL:168945; QTL:169690; QTL:169693;
   • RUNX3: RUNX family transcription factor 3
     evidenced by: QTL:173967;
   • SAA2: Serum amyloid A2
     evidenced by: QTL:64991; QTL:64992; QTL:64996;
   • SART3: Spliceosome associated factor 3, U4/U6 recycling protein
     evidenced by: QTL:49410;
   • SCRIB: Scribbled planar cell polarity protein
     evidenced by: QTL:174163;
   • SCRN1: Secernin 1
     evidenced by: QTL:16228;
   • SEC13: SEC13 homolog, nuclear pore and COPII coat complex component
     evidenced by: QTL:263572; QTL:263574; QTL:263576; QTL:263581; QTL:263584;
   • SEC22A: SEC22 homolog A, vesicle trafficking protein
     evidenced by: QTL:38461;
   • SEC23IP: SEC23 interacting protein
     evidenced by: QTL:53011;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41851;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43966;
   • SECISBP2: SECIS binding protein 2
     evidenced by: QTL:43752;
   • SERPINA1: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
     evidenced by: QTL:136275; QTL:14039;
   • SERPINA5: Serpin family A member 5
     evidenced by: QTL:125163;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52455;
   • SESN2: Sestrin 2
     evidenced by: QTL:168948; QTL:168951; QTL:168952; QTL:168957; QTL:168960; QTL:168963; QTL:168969; QTL:168973; QTL:168978; QTL:168993; QTL:168996; QTL:168999; QTL:169008; QTL:169012; QTL:169015; QTL:169021; QTL:169696; QTL:169700; QTL:169704;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52976;
   • SH3PXD2A: SH3 and PX domains 2A
     evidenced by: QTL:174337; QTL:174338; QTL:174339;
   • SHANK2: SH3 and multiple ankyrin repeat domains 2
     evidenced by: QTL:53974;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55633;
   • SHROOM3: Shroom family member 3
     evidenced by: QTL:174122;
   • SIRT1: Sirtuin 1
     evidenced by: QTL:314112;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48711;
   • SLC15A5: Solute carrier family 15 member 5
     evidenced by: QTL:174053;
   • SLC16A7: Solute carrier family 16 member 7
     evidenced by: QTL:40941;
   • SLC22A7: Solute carrier family 22 member 7
     evidenced by: QTL:256215; QTL:256219; QTL:256222; QTL:256226; QTL:256232; QTL:256273; QTL:256276;
   • SLC24A4: Solute carrier family 24 member 4
     evidenced by: QTL:51408;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39081;
   • SLC25A21: Solute carrier family 25 member 21
     evidenced by: QTL:51284;
   • SLC25A28: Solute carrier family 25 member 28
     evidenced by: QTL:174319;
   • SLC45A4: Solute carrier family 45 member 4
     evidenced by: QTL:174201; QTL:174202;
   • SLC4A4: Solute carrier family 4 member 4
     evidenced by: QTL:174109; QTL:175907;
   • SLC6A13: Solute carrier family 6 member 13
     evidenced by: QTL:175875; QTL:175876; QTL:175877;
   • SLC6A9: Solute carrier family 6 member 9
     evidenced by: QTL:47027;
   • SLC8A1: Solute carrier family 8 (sodium/calcium exchanger), member 1
     evidenced by: QTL:45243; QTL:45251;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:41448;
   • SLCO1C1: Solute carrier organic anion transporter family, member 1C1
     evidenced by: QTL:174026;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50317;
   • SLK: STE20 like kinase
     evidenced by: QTL:174340;
   • SMPD5: Sphingomyelin phosphodiesterase 5, pseudogene
     evidenced by: QTL:174155; QTL:175911;
   • SMYD1: SET and MYND domain containing 1
     evidenced by: QTL:45407;
   • SORCS3: Sortilin-related VPS10 domain containing receptor 3
     evidenced by: QTL:174343;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:42360;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39607;
   • SPATC1: Spermatogenesis and centriole associated 1
     evidenced by: QTL:223329;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:174127; QTL:174128; QTL:174129; QTL:43011; QTL:43031;
   • SPP1: Secreted phosphoprotein 1
     evidenced by: QTL:10038; QTL:10396;
   • SRC: V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
     evidenced by: QTL:13149;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41619;
   • ST3GAL1: ST3 beta-galactoside alpha-2,3-sialyltransferase 1
     evidenced by: QTL:174238; QTL:174239;
   • ST8SIA1: ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
     evidenced by: QTL:174016; QTL:174017; QTL:174018;
   • STIM1: Stromal interaction molecule 1
     evidenced by: QTL:174252;
   • STK3: Serine/threonine kinase 3
     evidenced by: QTL:168258;
   • SUCLG2: Succinate-CoA ligase GDP-forming subunit beta
     evidenced by: QTL:51580;
   • SUFU: Suppressor of fused homolog (Drosophila)
     evidenced by: QTL:174335;
   • SUN2: Sad1 and UNC84 domain containing 2
     evidenced by: QTL:41574;
   • SUPT3H: SPT3 homolog, SAGA and STAGA complex component
     evidenced by: QTL:175919;
   • SYN3: Synapsin III
     evidenced by: QTL:41202; QTL:41223;
   • SYT3: Synaptotagmin 3
     evidenced by: QTL:49870;
   • SYTL5: Synaptotagmin like 5
     evidenced by: QTL:54982;
   • TACC2: Transforming acidic coiled-coil containing protein 2
     evidenced by: QTL:156668; QTL:168269;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39343;
   • TBC1D12: TBC1 domain family member 12
     evidenced by: QTL:52686;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48962;
   • TBCD: Tubulin folding cofactor D
     evidenced by: QTL:50065;
   • TBX5: T-box 5
     evidenced by: QTL:156663; QTL:168263;
   • TCF7L2: Transcription factor 7-like 2 (T-cell specific, HMG-box)
     evidenced by: QTL:10199;
   • TENM2: Teneurin transmembrane protein 2
     evidenced by: QTL:43306;
   • TF: Transferrin
     evidenced by: QTL:12142;
   • TFCP2: Transcription factor CP2
     evidenced by: QTL:175878;
   • THRSP: Thyroid hormone responsive
     evidenced by: QTL:31688;
   • TM6SF2: Transmembrane 6 superfamily member 2
     evidenced by: QTL:181824;
   • TMC5: Transmembrane channel like 5
     evidenced by: QTL:52543;
   • TMCC3: Transmembrane and coiled-coil domain family 3
     evidenced by: QTL:175879; QTL:175880; QTL:175881;
   • TMTC1: Transmembrane O-mannosyltransferase targeting cadherins 1
     evidenced by: QTL:173989; QTL:173990;
   • TNFSF10: Tumor necrosis factor (ligand) superfamily, member 10
     evidenced by: QTL:16207;
   • TNK2: Tyrosine kinase non receptor 2
     evidenced by: QTL:168155;
   • TRAF3IP2: TRAF3 interacting protein 2
     evidenced by: QTL:43956;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:174215; QTL:174216; QTL:174217; QTL:174218; QTL:174219; QTL:174220; QTL:174221; QTL:47470; QTL:47483; QTL:47494;
   • TRIM3: Tripartite motif containing 3
     evidenced by: QTL:174247;
   • TRPS1: Transcriptional repressor GATA binding 1
     evidenced by: QTL:181825;
   • TSNARE1: T-SNARE domain containing 1
     evidenced by: QTL:174189; QTL:174190; QTL:174191; QTL:174192;
   • TTC27: Tetratricopeptide repeat domain 27
     evidenced by: QTL:156657; QTL:168166;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53605;
   • UBE2R2: Ubiquitin conjugating enzyme E2 R2
     evidenced by: QTL:174137;
   • UBOX5: U-box domain containing 5
     evidenced by: QTL:47171;
   • UGT1A6: UDP glucuronosyltransferase 1 family, polypeptide A6
     evidenced by: QTL:16157;
   • UGT2A1: UDP glucuronosyltransferase family 2 member A1 complex locus
     evidenced by: QTL:174107;
   • UHRF2: Ubiquitin like with PHD and ring finger domains 2
     evidenced by: QTL:43641;
   • USP24: Ubiquitin specific peptidase 24
     evidenced by: QTL:175846;
   • VPS28: VPS28, ESCRT-I subunit
     evidenced by: QTL:174148;
   • VSTM1: V-set and transmembrane domain containing 1
     evidenced by: QTL:174302;
   • VWA8: Von Willebrand factor A domain containing 8
     evidenced by: QTL:46194;
   • WDR17: WD repeat domain 17
     evidenced by: QTL:53303;
   • WWC3: WWC family member 3
     evidenced by: QTL:55577; QTL:55595;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47298;
   • ZBTB16: Zinc finger and BTB domain containing 16
     evidenced by: QTL:156662; QTL:168261;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40969;
   • ZC3H3: Zinc finger CCCH-type containing 3
     evidenced by: QTL:174168; QTL:174169;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52178;
   • ZNF16: Zinc finger protein 16
     evidenced by: QTL:174141;
   • ZNF335: Zinc finger protein 335
     evidenced by: QTL:47385;
   • ZNF404: Zinc finger protein 404
     evidenced by: QTL:49778;
   • ZNF407: Zinc finger protein 407
     evidenced by: QTL:52267;
   • ZNF45: Zinc finger protein 45
     evidenced by: QTL:49794;
   • ZNF696: Zinc finger protein 696
     evidenced by: QTL:174172;
   729 correlations are found involving Milk fat yield